Bold
Investors
ASX
Latest News
ASX Announcements
Companies
Home
ASX Announcements
COV Announcements
CLEO Optimises Biomarker Panel Ahead of…
COV
CLEO DIAGNOSTICS LTD
Market sensitive
CLEO Optimises Biomarker Panel Ahead of FDA Submission
Date and time
23 March 2026 at 7:29 pm
Announcement type
Company Update
Show details
Hide details
Category
Other
Report codes
11001
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
View on ASX
Open original PDF
COV announcement history
Recent COV announcements
Appendix 4G and Corporate Governance Statement
Appendix 4E and 2026 Annual Report
Quarterly activities and cashflow report
CLEO Enters Analytical Validation Phase
Change in Director's Interest Notice
Cleansing Notice